3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase 4
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Hypertension, Portal
1
Esophageal and Gastric Varices
1
Cardiotoxicity
1
Carcinoma, Hepatocellular
1
Interventions
sacubitril and valsartan sodium hydrate drug combination
1
Trastuzumab
1
Tablets
1
Spironolactone
1
Silymarin
1
Rosuvastatin Calcium
1
Carvedilol
1
Carnitine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cardiotoxicity
×
Carvedilol
×
Clear all
NCT04939883
2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4
Unknown
1,018 enrolled